| TRADING CENTER |
| What Bipartisan Health-Care Reform Means for Investors - MotleyFool.com | |
| This Stock Has Tremendous Upside - MotleyFool.com | |
| Make Thousands from Millions - MotleyFool.com | |
| Label Expansion for AZN Drug - Analyst Blog - Zacks.com | |
| Some Gray Amid the Black-and-White Thinking ($) - at TheStreet.com | |
| Pfizer's Slippery Slope - MotleyFool.com | |
| 3 Reasons to Move Beyond Index Funds - MotleyFool.com | |
| Don't Let Your Investments Blindside You - MotleyFool.com | |
| 5-Star Stocks Poised to Pop: ISTA Pharmaceuticals - MotleyFool.com | |
| INTERVIEW-Medivation mulls test of Dimebon-like drugs - Reuters | |
| U.S. clears wider use of AstraZeneca cholesterol drug - Reuters | |
| PREVIEW-Genzyme competition may get clearer at conference - Reuters | |
| The Government-Induced Drought - MotleyFool.com | |
| Good News About the Worst Year - MotleyFool.com | |
| Stock Market News for February 8, 2010 - Market News - Zacks.com |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 62.76 | 0.39 / 0.63% | 13.56 |
| NVS | Novartis AG | 53.58 | 0.50 / 0.94% | 14.52 |
| RHHBY | Roche Hldg Ltd | 41.50 | 0.57 / 1.39% | n/a |
| 2008 Revenue: | $48.3 B | Headquarters: New York, NY |
| Employees: | 81,800 | CEO: Jeffrey B. Kindler |
| Net Income: | $8.1 B | Industry: Pharmaceuticals |
| Market Cap: | $144.0 B | Website: www.pfizer.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| PFE | 17.88 | +0.04 / +0.22% | 17.84 | 18.15 | 17.65 | Profile Chart News |